VCV000036924.3 - ClinVar

NM_000570.4(FCGR3B):c.[108C=;194A>G;244A=;316A=]

Germline

Classification

The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.

(1)

Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.

Pathogenic

no assertion criteria provided

Somatic

No data submitted for somatic clinical impact

Somatic

No data submitted for oncogenicity

Variant Details

This haplotype includes the following variants

NM_000570.4(FCGR3B):c.[108C=;194A>G;244A=;316A=]

Other names: FCGR3B, ARG36SER, ASN65SER, ASP82ASN, AND VAL106ILE
neutrophil-specific NA2 antigen
Functional consequence: -
Links: ClinGen: CA044685; OMIM: 610665.0001

Genes

Gene	OMIM	ClinGen Gene Dosage Sensitivity Curation		Variation Viewer Help Links to Variation Viewer, a genome browser to view variation data from NCBI databases.	Related variants
Gene	OMIM	HI score Help The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.	TS score Help The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.		Within gene Help The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants.	All Help The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene.
FCGR3B		-	-	GRCh38 GRCh37	28	48

Conditions - Germline

Condition Help The condition for this variant-condition (RCV) record in ClinVar.	Classification Help The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions)	Review status Help The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status.	Last evaluated Help The most recent date that a submitter evaluated this variant for the condition.	Variation/condition record Help The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page.
Neutrophil-specific antigens NA1/NA2	Pathogenic (1)	no assertion criteria provided	Sep 7, 2018	RCV000030607.13

Submissions - Germline

Classification Help The submitted germline classification for each SCV record. (Last evaluated)	Review status Help Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria)	Condition Help The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant.	Submitter Help The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar.	More information Help This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter.
Pathogenic (Sep 07, 2018)	no assertion criteria provided Method: literature only	NEUTROPHIL-SPECIFIC ANTIGENS NA1/NA2 Affected status: not provided Allele origin: germline	OMIM Accession: SCV000053285.2 First in ClinVar: Apr 04, 2013 Last updated: Sep 10, 2018	Publications: PubMed (1) PubMed: 2523415 Comment on evidence: Ory et al. (1989) found nucleotide changes in the FCGR3B gene predicting 4 amino acid differences between the NA1 and NA2 alloantigens of neutrophils involved … (more) Ory et al. (1989) found nucleotide changes in the FCGR3B gene predicting 4 amino acid differences between the NA1 and NA2 alloantigens of neutrophils involved in alloimmune neonatal neutropenia. As a result, NA1 FCGR3 has only 4 potential N-linked glycosylation sites compared with 6 in NA2 FCGR3. In addition, Ory et al. (1989) found a silent nucleotide change at codon 38: CTC (leu38) in NA1; CTT (leu38) in NA2. (less)

Germline Functional Evidence

There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar.

Citations for germline classification of this variant

Title	Author	Journal	Year	Link
Characterization of polymorphic forms of Fc receptor III on human neutrophils.	Ory PA	The Journal of clinical investigation	1989	PMID: 2523415

Text-mined citations for this variant ...

Record last updated Nov 25, 2024

ClinVar Genomic variation as it relates to human health

NM_000570.4(FCGR3B):c.[108C=;194A>G;244A=;316A=]

Variant Details

NM_000570.4(FCGR3B):c.[108C=;194A>G;244A=;316A=]

Genes

Conditions - Germline

Submissions - Germline

Germline Functional Evidence

Citations for germline classification of this variant

Text-mined citations for this variant ...